View Press Releases
-
MicrobioSeq Boosts Scientific Research with Gene Expression Analysis
Nov 14, 2022
-
Vaxess Adds Fenel Eloi to Board of Directors
Eloi brings more than 30 years of life science leadership experience to Vaxess’ board; will advise company as it moves towards commercialization of MIMIX vaccine patch
Nov 28, 2022
-
Micro-Sphere Launches New Research & Development Services at Swiss Site
Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.
Nov 27, 2022
-
Flywheel Building Federated Data Platform for Development of Unbiased Breast Imaging AI
Flywheel is creating a federated data network aimed at improving AI for breast imaging—on a scale not previously possible.
Nov 27, 2022
-
Zebrafish Disease Model: Developed by Creative Biogene to Support Multiple Therapeutic Areas
Nov 27, 2022
-
IntegrateRNA Develops Premade Circular RNA Products to Satisfy Various Downstream Applications
Nov 27, 2022
-
Microbiosci Develops Data-independent Acquisition Proteomics to Support Molecular Diagnostics
Nov 27, 2022
-
Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media
Nov 27, 2022
-
Creative Bioarray Releases GMP Grade Cytokines to Support Cell Manufacturing and Cell-based Therapies
Nov 27, 2022
-
Acroscell Develops CiPA in Silico Modeling to Identify and Optimize Drug Candidates
Nov 27, 2022
-
FDA Approved ADC Drugs list up to 2022
Antibody-drug conjugates(ADCs) are use specific linkers to connect antibodies and small molecule cytotoxic drugs, and their main components include antibodies, linkers and small molecular cytotoxic drugs.
Nov 24, 2022
-
Alfa Chemistry Strengthens Its Analytical Testing Business with A Diversified Product & Service Portfolio
Analytical testing plays a pivotal role in nearly all fields and industries for quality and safety assurance. Fairly recently, the management team of Alfa Chemistry announced to further diversify its product & service portfolios, aiming to provide testing services as effectively and efficiently as possible to maximize customers' profits.
Nov 24, 2022
-
Embracing Innovation–BOC Sciences Strengthens the Production of Cosmetics Ingredients
It's verified by BOC Sciences officials that the critical specialty chemical distearyl phthalic acid amide is now in steady supply, aiming to accelerate the development of cosmetics industry.
Nov 23, 2022
-
Insecticides and Metabolite Standards
Nov 23, 2022
-
Polymer Characterization -- BOC Sciences
Nov 23, 2022
-
NCC Group Monthly Threat Pulse – October 2022 - Ransomware attacks decrease but DDoS attacks on the rise
Analysis from NCC Group’s Global Threat Intelligence team has revealed a decrease in ransomware attacks in October. However, there has been a notable shift in tactics, with more prevalent use of distributed denial of service (DDoS). In fact, October saw the highest number of DDoS incidents recorded this year.
Nov 22, 2022
-
Optibrium appoints Ian Smith as Chief Technology Officer
Optibrium appoints Ian Smith as Chief Technology Officer. New role will lead technology development as the Company continues to scale team and global business operations.
Nov 22, 2022
-
PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
Latest assays in PerkinElmer's growing CGT portfolio
Nov 20, 2022
-
Clinion Achieves GDPR Compliance – Strengthening patient data security
https://clinioncdn.azureedge.net/wp-content/uploads/2022/11/GDPR_compliance_banner.jpg
Nov 21, 2022
-
EMOTIV Partners with X-trodes to Launch New Medical-Grade, At-Home Solution for Brain Monitoring Research
Wearable Electrode Patches Provide Unprecedented Accuracy for Researchers Measuring Brain and Physiological Signals Outside the Lab, Expanding Possibilities for Real-World Clinical Studies
Nov 13, 2022


